The company aims to soon launch two tests to aid the treatment of dermatomycosis and is developing other tests for healthcare ...

The White House has moved to fill out its legislative affairs office that will work with lawmakers on Capitol Hill on budget ...

In other Revvity news, insider Joel S. Goldberg sold 15,170 shares of Revvity stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $126.73, for a total ...

KeyBanc raised the firm’s price target on Revvity (RVTY) to $145 from $132 and keeps an Overweight rating on the shares. The firm notes that having pre-announced Q4 in mid-January, all eyes were ...

KeyBanc analyst Paul Knight maintained a Buy rating on Revvity (RVTY – Research Report) today and set a price target of $145.00. The company’s shares closed last Friday at $126.13. Leverage ...

Revvity Inc. reported its financial results for the fourth quarter of 2024, revealing a slight beat in earnings per share (EPS) but a miss on revenue expectations. The company's actual EPS of $1.42 ...

Revvity Inc. reported its financial results for the fourth quarter of 2024, revealing a slight beat in earnings per share (EPS) but a miss on revenue expectations. The company's actual EPS of $1. ...

Matthew Sykes; Analyst; Goldman Sachs Group, Inc. Hello, everyone, and welcome to Revvity's fourth-quarter 2024 earnings call. My name is Lydia, and I will be your operator today. (Operator ...